Silicogenix

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

655 Oak Grove Ave 1417, Menlo Park, Cali...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Silicogenix

Silicogenix Inc is an AI-native, preclinical stage precision oncology company focused on developing small molecule therapeutics for rare and ultra-rare cancers. The company employs a massively parallel, Many-To-Many (M2M) model to evaluate multiple targets and therapeutic modalities, aiming to enhance the success rate of drug development. Silicogenix is built by pioneers in network biology and computational systems, utilizing a proprietary technology stack to drive innovation in drug discovery. Their current pipeline includes the development of inhibitors for Ewing Sarcoma, with plans to expand into other rare oncology indications.Explore more
Popular SearchesSilicogenixSIC Code 28,283NAICS Code 32,325Show more

Is Silicogenix your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Frequently Asked Questions Regarding Silicogenix

What is Silicogenix's official website?
Silicogenix's official website is www.silicogenix.com
What is Silicogenix's Revenue?
Silicogenix's revenue is <$5 Million
What is Silicogenix's SIC code?
Silicogenix's SIC: 28,283
What is Silicogenix's NAICS code?
Silicogenix's NAICS: 32,325
How many employees does Silicogenix have?
Silicogenix has 11-50 employees
What industry does Silicogenix belong to?
Silicogenix is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What does Silicogenix do?

Silicogenix Inc is an AI-native, preclinical stage precision oncology company focused on developing small molecule therapeutics for rare and ultra-rare cancers. The company employs a massively parallel, Many-To-Many (M2M) model to evaluate multiple targets and therapeutic modalities, aiming to enhance the success rate of drug development. Silicogen... ix is built by pioneers in network biology and computational systems, utilizing a proprietary technology stack to drive innovation in drug discovery. Their current pipeline includes the development of inhibitors for Ewing Sarcoma, with plans to expand into other rare oncology indications.Read More

Is Silicogenix a public company?
Silicogenix is private company therefore does not currently have an official ticker symbol
See more information about Silicogenix

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.